F-18 labelled 'Pittsburgh compound B'

F-18 labelled “Pittsburgh compound B” or F18-PIB is a new, promising proprietary PET scanning agent for early imaging / detection of Alzheimers disease. The compound is owned by GE-Health Care, but we have been invited to assist in the early clinical trials as GMP compliant manufacturer of this new experimental drug.

Over a period of 3 years, we have set-up and validated the production and are now supplying clinical trials at Rigshospitalet in Copenhagen and elsewhere.

Contact

Mikael Jensen
Professor
DTU Nutech
+45 46 77 53 59